scholarly journals Systems biology of the metabolism of Mycobacterium tuberculosis

2010 ◽  
Vol 38 (5) ◽  
pp. 1286-1289 ◽  
Author(s):  
Dany J.V. Beste ◽  
Johnjoe McFadden

Despite decades of research, many aspects of the biology of Mycobacterium tuberculosis remain unclear, and this is reflected in the antiquated tools available to treat and prevent tuberculosis and consequently this disease remains a serious public health problem. Important discoveries linking the metabolism of M. tuberculosis and pathogenesis has renewed interest in this area of research. Previous experimental studies were limited to the analysis of individual genes or enzymes, whereas recent advances in computational systems biology and high-throughput experimental technologies now allows metabolism to be studied on a genome scale. In the present article, we discuss the progress being made in applying system-level approaches to study the metabolism of this important pathogen.

2008 ◽  
Vol 5 (1) ◽  
pp. 57-71 ◽  
Author(s):  
Nicola Segata ◽  
Enrico Blanzieri ◽  
Corrado Priami

Summary The paradigmatic shift occurred in biology that led first to high-throughput experimental techniques and later to computational systems biology must be applied also to the analysis paradigm of the relation between local models and data to obtain an effective prediction tool. In this work we introduce a unifying notational framework for systems biology models and high-throughput data in order to allow new integrations on the systemic scale like the use of in silico predictions to support the mining of gene expression datasets. Using the framework, we propose two applications concerning the use of system level models to support the differential analysis of microarray expression data. We tested the potentialities of the approach with a specific microarray experiment on the phosphate system in Saccharomyces cerevisiae and a computational model of the PHO pathway that supports the systems biology concepts.


Cancers ◽  
2020 ◽  
Vol 13 (1) ◽  
pp. 35
Author(s):  
Sahar Aghakhani ◽  
Naouel Zerrouk ◽  
Anna Niarakis

Fibroblasts, the most abundant cells in the connective tissue, are key modulators of the extracellular matrix (ECM) composition. These spindle-shaped cells are capable of synthesizing various extracellular matrix proteins and collagen. They also provide the structural framework (stroma) for tissues and play a pivotal role in the wound healing process. While they are maintainers of the ECM turnover and regulate several physiological processes, they can also undergo transformations responding to certain stimuli and display aggressive phenotypes that contribute to disease pathophysiology. In this review, we focus on the metabolic pathways of glucose and highlight metabolic reprogramming as a critical event that contributes to the transition of fibroblasts from quiescent to activated and aggressive cells. We also cover the emerging evidence that allows us to draw parallels between fibroblasts in autoimmune disorders and more specifically in rheumatoid arthritis and cancer. We link the metabolic changes of fibroblasts to the toxic environment created by the disease condition and discuss how targeting of metabolic reprogramming could be employed in the treatment of such diseases. Lastly, we discuss Systems Biology approaches, and more specifically, computational modeling, as a means to elucidate pathogenetic mechanisms and accelerate the identification of novel therapeutic targets.


Author(s):  
Florencio Pazos ◽  
David Guijas ◽  
Manuel J. Gomez ◽  
Almudena Trigo ◽  
Victor de Lorenzo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document